Pfizer Inc expects to deliver more than 13 million doses of its COVID-19 vaccine per week to the United States by mid-March, more than double its shipments since early February, a senior Pfizer executive said in testimony prepared before a Congress on Tuesday. audience.
Pfizer has shipped about 40 million doses to locations in the United States so far and is on track to deliver 120 million doses of its two-dose regimen by the end of March, said John Young, Pfizer’s chief commercial officer.
PFIZER SAYS SOUTH AFRICA VARIANT COULD SIGNIFICANTLY REDUCE PROTECTION AGAINST COVID-19 VACCINE
He added that Pfizer is also set to provide a total of 300 million injections to the United States by the end of July and has raised global production expectations for 2021 to at least 2 billion doses.
In his own prepared remarks, Moderna Inc president Stephen Hoge said the drugmaker plans to administer 100 million doses of its two-dose injection by the end of March and 300 million by the end of July.
|JNJ||JOHNSON AND JOHNSON||161.87||-0.10||-0.06%|
Johnson & Johnson believes it will be able to ship at least 20 million doses of its single-dose injection to the United States by the end of March after receiving regulatory clearance from the United States, said Vice President of Medical Affairs Richard Nettles. It expects to ship 100 million doses by mid-2021, he said.
FOR COVID-19 SURVIVORS, ONE SHOT MAY BE ENOUGH, PRELIMINARY STUDIES SHOW
Comments from drug makers put the United States on track to receive 240 million doses by the end of March, enough to inoculate 130 million Americans, and 700 million doses by mid-year, more than enough to dose everyone. the American population.
The comments were prepared ahead of a congressional hearing on vaccine availability to be held by the House of Representatives Committee on Energy and Commerce on Tuesday.
CLICK HERE TO READ MORE ABOUT FOX BUSINESS